Renephra Company

Renephra is a medical device company developing a groundbreaking Transdermal Fluid Removal (TFR) technology for minimally invasive fluid removal. It can solve fluid overload and chronic oedema/lymphoedema in vascular, oncology and other disease areas. The Renephra patented Fluid Removal Device uses micro-needle technology combined with negative pressure therapy to access and remove excess interstitial fluid from the skin. The goal is to provide a safe, gentle, and simple medical device for patients to use as a home. Renephra's team envisages that the device will be applied daily by a district or heart failure nurse who visits these patients during exacerbations of their condition. It is planned that the patient removes the device at the end of therapy and changes the canister if it gets packed during treatment.

Investors

Connections from

Estimated Revenue: £780 000- £7 800 000
Funding Status: Private
Industry: P4 medicine
Investors Number: 8
Last Funding Date: 12-19-2018
Founded Date: 2008
Headquarters: Manchester, United Kingdom
Total Funding: £429 158
Last Funding Type: Venture - Series Unknown
Employee Number: 11-50
Register and Claim Ownership